Medicenna Therapeutics Corp. (MDNA) Reports $3.7M Cash and Says Financing Is Needed
Medicenna Therapeutics reported $3.7M in cash, down from $5.7M, and stated it needs additional financing to fund operations for the next 12 months. The company's quarterly net loss was $4.0M, an improvement from $4.9M in the same period last year, but financing is not guaranteed.
